Comparison of 18F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of 18F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression
Authors
Keywords
CXCR4, PET imaging, CXCR4 antagonist peptides, <sup>18</sup>F-labeling
Journal
MOLECULAR IMAGING AND BIOLOGY
Volume 15, Issue 6, Pages 758-767
Publisher
Springer Nature
Online
2013-05-02
DOI
10.1007/s11307-013-0640-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Innate Immunity Derived Factors as External Modulators of the CXCL12 - CXCR4 Axis and Their Role in Stem Cell Homing and Mobilization
- (2013) Mariusz Z. Ratajczak et al. Theranostics
- CXCR4/CXCL12 Axis in Non Small Cell Lung Cancer (NSCLC) Pathologic Roles and Therapeutic Potential
- (2013) Ori Wald et al. Theranostics
- Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory Bowel Disease
- (2013) Lael Werner et al. Theranostics
- Role of CXCR4 in the Pathogenesis of Acute Myeloid Leukemia
- (2013) Amnon Peled et al. Theranostics
- The Role of CXCL12-CXCR4 Signaling Pathway in Pancreatic Development
- (2013) Keiichi Katsumoto et al. Theranostics
- Synthesis and in vitro evaluation of 68Ga-DOTA-4-FBn-TN14003, a novel tracer for the imaging of CXCR4 expression
- (2012) Ute Hennrich et al. BIOORGANIC & MEDICINAL CHEMISTRY
- PET imaging of CXCR4 using copper-64 labeled peptide antagonist
- (2012) Orit Jacobson et al. Theranostics
- Comparison Study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET Imaging of U87MG Tumors in Mice
- (2011) Lixin Lang et al. BIOCONJUGATE CHEMISTRY
- Synthesis and Evaluation of a Bimodal CXCR4 Antagonistic Peptide
- (2011) Joeri Kuil et al. BIOCONJUGATE CHEMISTRY
- PET Imaging of CXCR4 Receptors in Cancer by a New Optimized Ligand
- (2011) Oliver Demmer et al. ChemMedChem
- Improvement of CXCR4 tracer specificity for PET imaging
- (2011) Orit Jacobson et al. JOURNAL OF CONTROLLED RELEASE
- Design, Synthesis, and Functionalization of Dimeric Peptides Targeting Chemokine Receptor CXCR4
- (2011) Oliver Demmer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Imaging CXCR4 Expression in Human Cancer Xenografts: Evaluation of Monocyclam 64Cu-AMD3465
- (2011) R. A. De Silva et al. JOURNAL OF NUCLEAR MEDICINE
- Positron Emission Tomography Imaging of Tumors Expressing the Human Chemokine Receptor CXCR4 in Mice with the Use of 64Cu-AMD3100
- (2011) Ido D. Weiss et al. MOLECULAR IMAGING AND BIOLOGY
- Automated radiochemical synthesis of [18F]FBEM: A thiol reactive synthon for radiofluorination of peptides and proteins
- (2010) Dale O. Kiesewetter et al. APPLIED RADIATION AND ISOTOPES
- Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100 Positron Emission Tomography
- (2010) S. Nimmagadda et al. CANCER RESEARCH
- PET of Tumor CXCR4 Expression with 4-18F-T140
- (2010) O. Jacobson et al. JOURNAL OF NUCLEAR MEDICINE
- 64Cu-AMD3100—A novel imaging agent for targeting chemokine receptor CXCR4
- (2009) Orit Jacobson et al. BIOORGANIC & MEDICINAL CHEMISTRY
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting
- (2009) Antonina V. Kurtova et al. BLOOD
- Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer
- (2008) Shiwu Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started